Dermapharm Holding SE (DMP) — Cash Flow Quality Index
Dermapharm Holding SE (DMP) has a Cash Flow Quality Index of 0.87x as of March 2026. Operating cash flow of €39.49 Million is below net income of €45.20 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Dermapharm Holding SE cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Dermapharm Holding SE Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Dermapharm Holding SE across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check DMP capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Dermapharm Holding SE (2014–2025)
Year-by-year earnings quality comparison for Dermapharm Holding SE. For live market cap and the full company financial profile, see market cap of Dermapharm Holding SE.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | €181.51 Million | €132.41 Million | ▲ +17.1% |
| 2024 | 1.17x | €201.38 Million | €172.00 Million | ▼ -66.7% |
| 2023 | 3.52x | €219.42 Million | €62.37 Million | ▲ +163.7% |
| 2022 | 1.33x | €288.53 Million | €216.30 Million | ▲ +56.1% |
| 2021 | 0.85x | €250.37 Million | €292.98 Million | ▼ -18.3% |
| 2020 | 1.05x | €131.10 Million | €125.28 Million | ▲ +14.5% |
| 2019 | 0.91x | €100.61 Million | €110.07 Million | ▼ -56.8% |
| 2018 | 2.12x | €159.13 Million | €75.23 Million | ▲ +89.6% |
| 2017 | 1.12x | €86.74 Million | €77.74 Million | ▼ -75.2% |
| 2016 | 4.50x | €76.78 Million | €17.06 Million | ▲ +43.7% |
| 2015 | 3.13x | €40.38 Million | €12.90 Million | ▼ -98.6% |
| 2014 | 228.93x | €54.26 Million | €237.00K | — |